SCIENTIFIC EVIDENCE

NCAPG as a Novel Prognostic Biomarker in Glioma.

Frontiers in oncology
Jiang X, Shi Y, Chen X, Xu H, Liu B, Zhou F, Huang X, Cho WC, Li L, Pu J, Pu J.

Publication Overview

Key findings, Countstar context, and access to the original paper.
2022
Cancer Research
No items found.
Key Finding
Gene set enrichment analysis (GSEA) indicated that high NCAPG expression was associated with cell proliferation and immune response-related signaling pathways. NCAPG knockdown in glioma cell lines significantly reduced cell survival, proliferation, and migration.
Countstar Connection
The researchers measured flow-cytometry cell measurements in the study's cell samples with Countstar (model not specified) during migration assessment in the 2022 Frontiers in oncology study.
Stay Connected toCountstar Science
Get new publications, application notes, cell analysis insights, and Countstar updates delivered to your inbox.
Meet us online